Nota: O uso do produto no recomendado para gestantes, lactantes ou menores de 18 anos sem orientao mdica
"Non-pyrogenic" just means it is made to be free of the leftovers that cause fevers
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
only the format differs
the injection is done after the HCG liquid is drawn into a syringe and the trapped air is removed
they offer a boost in energy, an uplift in mood, sharper cognitive functions, and even support in weight management efforts